Novel medicinal composition, especially for the treatment of cel

Details Novel medicinal composition, especially for the treatment of cel Novel medicinal composition, especially for the treatment of cel

1978-01-24

1980-03-04

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424151, 424253, A61K 3748, A61K 3316, A61K 3152

Patent

active

041917480

ABSTRACT:
The composition results essentially from the combination of a phosphodiesterase inhibitor and a fluorinated compound. Preferably it comprises theophylline, thiomucase or hyaluronidase, and sodium fluoride, in dosage unit form for topical, injection or ionization local administration.

REFERENCES:
patent: 2976212 (1961-03-01), Fredrich et al.
patent: 3978213 (1976-08-01), Lapinet et al.
Merck Index, 9th ed., 1976, p. 1114 (8368).

Affiliated with

Also associated with

Rating

Novel medicinal composition, especially for the treatment of cel does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel medicinal composition, especially for the treatment of cel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel medicinal composition, especially for the treatment of cel will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2039977